Cannabidiol Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.
Amplifying sales of cannabidiol-derived products on account of their role in medical applications have been driving the growth graph of cannabidiol market share. CBD-based products have gained massive demand after passing of the Farm Bill in 2018, especially in developed nations, such as Canada, Netherlands, the U.S., and France. Also, changing regulatory landscape pertaining to the approval of cannabidiol-derived products will further spur cannabidiol industry growth.
Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/4541
As per a research report published by Global Market Insights, Inc., cannabidiol market size is expected to surpass $89.0 billion in revenue by 2026.
Based on the product segment, cannabidiol market can be bifurcated into tinctures, isolates, vape oils, oils, suppository, tablets, roll-ons, transdermal patches, capsules, creams, and others. Among these, capsules segment is expected to register huge profits due to their increasing applications and easy consumption process.
Cannabidiol capsules are also safe enough to be given to children with severe neurological disorders, including epilepsy and Parkinson’s disease. These applications are likely to lead cannabidiol capsules segment to witness a 53.4% CAGR over 2020-2026.
Based on the source, cannabidiol market is divided into hemp and marijuana. Between both, hemp segment is expected to witness a double-digit CAGR over the forecast timeframe due to the legalized farming of hemp in several countries and its use to treat various disorders.
Hemp has a dash of THC and a large amount of CBD, which has found extensive applications for the treatment of various ailments. Hemp contains THC, a psychoactive substance, which has resulted in legitimate farming of hemp instead of marijuana. In accordance, hemp segment is anticipated to record a 53.10% CAGR over the forecast period.
Cannabidiol-based products are used for the treatment of chronic pain, skincare, neurological conditions, anxiety/stress, migraine, sleep/insomnia, joint & inflammation, seizures, and others. Several neurological disorders, such as epilepsy, Parkinson’s disease, Alzheimer’s disease, and others, cause nausea & seizures, which can be reduced by the use of cannabidiol.
Estimates claim that in the U.S., almost 1.2% of the total population is suffering from epilepsy and about 5.5 million people are afflicted with Alzheimer’s disease. These surging numbers of patients with neurological disorders and growing use of cannabidiol for their treatment will push the growth graph of the industry in the ensuing years.
It has been speculated that cannabidiol market size from neurological segment is anticipated to witness a 51.8% CAGR over 2020-2026.
Peru has recently legalized the farming of cannabis and its derivatives for medicinal and therapeutic usage. The country has an appropriate climate for cannabis farming and low labor costs, resulting in 5 harvests in a year. Peru is also witnessing intensifying awareness among the masses pertaining to hemp farming and its benefits.
Several players in the country are adopting various business strategies, such as partnerships and collaborations to support the use of cannabis. This can be evidenced by the partnership of Canopy Growth Corporation and Spectrum Cannabis Peru in January 2019. Both the companies teamed up to introduce new regulations, support patient access, and encourage education to use medical cannabis. The partnership also generated several growth opportunities for Canopy Corporation.
Estimates claim that Peru cannabidiol industry will register a CAGR of 59.5% over the forecast period.
Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/cannabidiol-cbd-market
Partial Chapter of the Table of Content
Chapter 4. Cannabidiol Market, By Product
4.1. Key segment trends
4.2. Oil
4.2.1. Market size, by region, 2015-2026 (USD Million)
4.3. Tinctures
4.3.1. Market size, by region, 2015-2026 (USD Million)
4.4. Suppositories
4.4.1. Market size, by region, 2015-2026 (USD Million)
4.5. Transdermal Patches
4.5.1. Market size, by region, 2015-2026 (USD Million)
4.6. Isolates
4.6.1. Market size, by region, 2015-2026 (USD Million)
4.7. Isolates
4.7.1. Market size, by region, 2015-2026 (USD Million)
4.8. Tablets
4.8.1. Market size, by region, 2015-2026 (USD Million)
4.9. Capsules
4.9.1. Market size, by region, 2015-2026 (USD Million)
4.10. Vape oils
4.10.1. Market size, by region, 2015-2026 (USD Million)
4.11. Creams and roll-ons
4.11.1. Market size, by region, 2015-2026 (USD Million)
4.12. Others
4.12.1. Market size, by region, 2015-2026 (USD Million)
Chapter 5. Cannabidiol Market, By Application
5.1. Key segment trends
5.2. Anxiety/stress
5.2.1. Market size, by region, 2015-2026 (USD Million)
5.3. Sleep/insomnia
5.3.1. Market size, by region, 2015-2026 (USD Million)
5.4. Chronic pain
5.4.1. Market size, by region, 2015-2026 (USD Million)
5.5. Migraine
5.5.1. Market size, by region, 2015-2026 (USD Million)
5.6. Skin care
5.6.1. Market size, by region, 2015-2026 (USD Million)
5.7. Seizures
5.7.1. Market size, by region, 2015-2026 (USD Million)
5.8. Joint pain & inflammation
5.8.1. Market size, by region, 2015-2026 (USD Million)
5.9. Neurological conditions
5.9.1. Market size, by region, 2015-2026 (USD Million)
5.10. Others
5.10.1. Market size, by region, 2015-2026 (USD Million)